Promoting Self-Management in Adults With Type 2 Diabetes: Development of the Impact of Glucose Monitoring on Self-Management Scale

被引:0
作者
Vallis, Michael [1 ]
Berard, Lori [2 ]
Cosson, Emmanuel [3 ,4 ,5 ]
Kristensen, Finn Boerlum [6 ]
Levrat-Guillen, Fleur [7 ]
Naiditch, Nicolas [8 ]
Rabasa-Lhoret, Remi [9 ,10 ]
Polonsky, William [11 ]
机构
[1] Dalhousie Univ, Family Med, Halifax, NS, Canada
[2] Pink Pearls Inc, Winnipeg, MB, Canada
[3] Avicenne Hosp, AP HP Hop Univ Paris Seine St Denis, Bobigny, France
[4] Univ Sorbonne Paris Nord, Equipe Rech Epidemiol Nutr, Bobigny, France
[5] Univ Paris Cite, Ctr Res Epidemiol & Stat, INSERM, INRAE,CNAM, Bobigny, France
[6] Univ South Denmark, Dept Publ Hlth, Res Unit User Perspect, Odense, Denmark
[7] Abbott Diabet Care, Maidenhead, England
[8] Federat Francaise Diabet, Paris, Ile De France, France
[9] Inst Rech Clin Montreal, Montreal, PQ, Canada
[10] Univ Montreal, Montreal, PQ, Canada
[11] Behav Diabet Inst, San Diego, CA USA
关键词
continuous glucose monitoring; motivation; patient-reported outcome; self-management; DEVICE;
D O I
10.1016/j.jcjd.2024.07.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Type 2 diabetes (T2D) management requires behavioural engagement to achieve optimal outcomes and continuous glucose monitoring (CGM) technologies may facilitate self-management. In this study, we describe the development and validation of a self-report instrument, the Impact of Glucose Monitoring on Self-Management Scale (IGMSS), assessing the impact of device use (primarily CGM but also self-monitored blood glucose [SMBG]) on the capability, motivation, and opportunity to engage in self-management. Methods: Potential items were generated from 3 sources: themes and quotes from 13 adults with T2D motivated by CGM use who participated in a qualitative study; behaviour change theory identifying capability, opportunity, and motivation to self-manage; and expert committee review of items. An initial pool of 42 items were generated describing CGM as promoting personalized knowledge, improved health (Capability), improved relationships, having positive device characteristics (Opportunity), and improved engagement in self-management (Motivation). Based on expert committee consensus, items were written so as to be completed by those using any glucose-sensing device (SMBG and CGM). Psychometric evaluation was conducted with 514 English-speaking Canadians. Scale reduction (22 final items) was completed using item-response distribution, internal consistency, factor analysis, and expert opinion. Construct and convergent validity were evaluated using the Impact of Glucose Monitoring Satisfaction Scale, the Diabetes Self-Management Questionnaire, the Diabetes Distress Scale, the 5-item World Health Organization Well-Being Index, and the Centre for Epidemiology Depression Scale. Test-retest reliability was determined for 130 participants. Results: Internal consistency was high for all scales, ranging from 0.73 to 0.91. Test-retest reliability ranged from 0.58 to 0.79, except for Device Characteristics. Construct and convergent validity indices were acceptable. There was substantial overlap between the IGMSS and established measures of CGM satisfaction. IGMSS findings were also predictive of self-management behaviour and emotional functioning. Conclusions: The IGMSS has positive psychometric characteristics and has the potential to screen people with T2D for engagement in diabetes self-management using CGM or any sensing device. Scores can be determined for various aspects of Capability (Personalized Knowledge, Improved Health), Opportunity (Relationships and Device Characteristics), and Motivation. (c) 2024 The Author(s). Published by Elsevier Inc. on behalf of Canadian Diabetes Association. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页码:452 / 461.e1
页数:11
相关论文
共 18 条
  • [11] OXMAN AD, 1995, CAN MED ASSOC J, V153, P1423
  • [12] Assessing psychosocial distress in diabetes - Development of the Diabetes Distress Scale
    Polonsky, WH
    Fisher, L
    Earles, J
    Dudl, RJ
    Lees, J
    Mullan, J
    Jackson, RA
    [J]. DIABETES CARE, 2005, 28 (03) : 626 - 631
  • [13] Development of a New Measure for Assessing Insulin Delivery Device Satisfaction in Patients with Type 1 and Type 2 Diabetes
    Polonsky, William H.
    Fisher, Lawrence
    Hessler, Danielle
    Edelman, Steven V.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2015, 17 (11) : 773 - 779
  • [14] The Diabetes Self-Management Questionnaire (DSMQ): development and evaluation of an instrument to assess diabetes self-care activities associated with glycaemic control
    Schmitt, Andreas
    Gahr, Annika
    Hermanns, Norbert
    Kulzer, Bernhard
    Huber, Joerg
    Haak, Thomas
    [J]. HEALTH AND QUALITY OF LIFE OUTCOMES, 2013, 11
  • [15] U.S. Food and Drug Administration, 2009, Guidance for Industry: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims
  • [16] How Continuous Glucose Monitoring Can Motivate Self-management: Can Motivation Follow Behaviour?
    Vallis, Michael
    Ryan, Hana
    Berard, Lori
    Cosson, Emmanuel
    Kristensen, Finn Boerlum
    Levrat-Guillen, Fleur
    Naiditch, Nicolas
    Rabasa-Lhoret, Remi
    Polonsky, William
    [J]. CANADIAN JOURNAL OF DIABETES, 2023, 47 (05) : 435 - 444
  • [17] WHO, 2003, Adherence to Long-term Therapies: Evidence for Action
  • [18] Use of a real time continuous glucose monitoring system as a motivational device for poorly controlled type 2 diabetes
    Yoo, H. J.
    An, H. G.
    Park, S. Y.
    Ryu, O. H.
    Kim, H. Y.
    Seo, J. A.
    Hong, E. G.
    Shin, D. H.
    Kim, Y. H.
    Kim, S. G.
    Choi, K. M.
    Park, I. B.
    Yu, J. M.
    Baik, S. H.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 82 (01) : 73 - 79